Table 1.
Strain | Kinin-forming
activity
|
Endogenous bradykinin
|
|||||||
---|---|---|---|---|---|---|---|---|---|
pg of BK/h per μg of protein
|
ng of
BK/min per 24-h excretion
|
fmol/g of tissue
|
|||||||
Kidneys, n = 7 | Colon, n = 7 | Pancreas, n = 15 | Salivary glands, n = 7 | Heart, n = 7 | Urine, n = 6 | Feces, n = 14 | Kidneys, n = 16 | Heart, n = 16 | |
+/+ | 32.6 ± 6.1 | 32.7 ± 11.5 | 5,077 ± 1,364 | 518,743 ± 114,978 | 1.6 ± 1.1 | 2,384 ± 164 | 1,708 ± 452 | 9.2 ± 1.4 | <X |
+/− | 12.3 ± 2.4 | 11.6 ± 5.3 | 1,846 ± 805 | 118,800 ± 19,697 | 0.8 ± 0.6 | 887 ± 173 | 958 ± 334 | NM | NM |
−/− | 1.2 ± 0.4 | 1.8 ± 1.0 | 14 ± 2 | 7,629 ± 1,856 | 1.2 ± 0.4 | 10 ± 1 | 17 ± 2 | 2.1 ± 0.5 | <X |
P | 0.0001 | 0.02 | 0.0008 | 0.0001 | 0.56 | 0.0001 | 0.002 | 0.0001 | NA |
The detection limit X of endogenous bradykinin (BK) was 1.3 fmol/g of tissue. Values (means ± SEM) have been compared by ANOVA. NM, not measured; NA, not applicable.